Visakhapatnam

Granules India’s Vizag facility completes US FDA inspection with zero 483 observations

Read more

Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet  

Read more

Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India

Read more

Natco Pharma gets USFDA approval for Visakhapatnam facility

Read more

Divi’s Laboratories begins commercial production at Visakhapatnam unit

Read more

Laurus Labs receives EIR from US FDA for Visakhapatnam units

Read more